Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01235910 · ClinicalTrials.gov registry record · Phase 4
Clinical Pharmacology of Aliskiren in Combination With Cyclosporine in Cardiac Transplantation
A Phase 4 study, sponsored by University of Colorado, Denver.
- Terminated
- Registry status
- Phase 4
- Development phase
- 1
- Enrollment target
NCT01235910 is a Phase 4 study that was terminated before completion, run by University of Colorado, Denver. The registered enrollment target is 1 participants.
The verdict
NCT01235910, a Phase 4 study, was terminated before completion, sponsored by University of Colorado, Denver.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 1 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and efficacy of the blood pressure medication, aliskiren, in heart transplant patients. In terms of safety, the investigators will evaluate the blood levels of aliskiren and determine if aliskiren alters the blood levels of the anti-rejection medication, cyclosporine, in these patients. In terms of efficacy, the investigators will determine how well aliskiren lowers blood pressure in heart transplant patients.
Interventions
- DRUG Aliskiren
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2011-05 |
| Est. Completion | 2012-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01235910
The ClinicalTrials.gov registry entry for NCT01235910 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Aliskiren is the first listed.
NCT01235910 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01235910 about?
NCT01235910 is a clinical study titled "Clinical Pharmacology of Aliskiren in Combination With Cyclosporine in Cardiac Transplantation". The purpose of this study is to evaluate the safety and efficacy of the blood pressure medication, aliskiren, in heart transplant patients. In terms of safety, the investigators will evaluate the blood levels of aliskiren and determine if aliskiren alters the blood levels of the anti-rejection medic...
What is the current status of trial NCT01235910?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 1 participants. The study started on 2011-05. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01235910?
The interventions under investigation include: Aliskiren (DRUG).
Who is sponsoring clinical trial NCT01235910?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.